Sun Pharma shares in focus after US launch of LEQSELVITM, Incyte settlement



Sun Pharma shares will be in focus on July 15 after the company announced the US launch of LEQSELVITM (deuruxolitinib) for severe alopecia areata and a settlement agreement with Incyte Corporation related to the same drug.

Comments